AIDX.TO Healwell AI pre-market C$0.96 18 Mar 2026: AI stock setup into earnings

AIDX.TO stock trades at C$0.96 pre-market on the TSX as Healwell AI Inc. prepares to report results on 19 Mar 2026. Volume sits at 466,396 shares versus a 50-day average of 560,877. The company shows a year high of C$1.81 and a year low of C$0.58. Investors watching AI healthcare names should weigh near-term earnings risk against growing AI adoption in preventative care.

AIDX.TO stock: Pre-market snapshot and price action

Healwell AI Inc. (AIDX.TO) opened pre-market at C$0.97 and last traded at C$0.96. Intraday range runs C$0.93–C$0.98 while average daily volume is 560,877. Market cap on the TSX stands at C$267,261,857. Recent 1-month return is +52.38%, highlighting short-term interest ahead of earnings.

AIDX.TO stock: Fundamentals and financial metrics

Trailing EPS is -0.23 and the reported P/E is -4.17, reflecting losses. Price-to-sales is 2.64 and price-to-book is 1.88. Current ratio is 0.85, and debt-to-equity is 0.74, showing tighter liquidity and moderate leverage. Revenue per share last twelve months is 0.42 and free cash flow per share is -0.11.

AIDX.TO stock: Technicals and trading signals

Momentum indicators show RSI 64.39 and MACD histogram 0.03, indicating bullish momentum. The 50-day average is C$0.80 and the 200-day average is C$1.16, placing price between short and long term averages. Bollinger upper band is C$0.98 which caps upside near current levels. On-balance volume is negative but money flow index is high at 73.80.

AIDX.TO stock: Earnings catalyst and near-term events

Healwell AI reports earnings on 19 Mar 2026 at 08:30 EDT. Analyst focus will be on revenue growth and margins in AI-enabled care. Management commentary on the WELL Health alliance could move the stock. For background on market quoting and commentary see CNBC AIDX quote and news.

AIDX.TO stock: Valuation, sector context, and risks

Healthcare peers show an average P/E around 19.82 while AIDX.TO shows a negative P/E. The stock trades at EV/sales 3.37 and EBITDA multiples are negative. Key risks include cash flow pressure, a current ratio under 1.00, and prolonged losses. Opportunities include higher AI adoption and strategic partnerships with WELL Health.

Meyka AI rates AIDX.TO with a score out of 100 and the model forecast

Meyka AI rates AIDX.TO with a score of 62.15 out of 100, grade B, suggestion HOLD. This grade factors in S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a quarterly price of C$0.72, implying -25.00% from the current C$0.96. Forecasts are model-based projections and not guarantees. See our internal stock page for more detail: Meyka AIDX.TO page.

Final Thoughts

AIDX.TO stock trades at C$0.96 in pre-market on the TSX with a clear earnings catalyst on 19 Mar 2026. Fundamentals show a negative EPS of -0.23 and a negative P/E of -4.17, while short-term technicals show momentum. Meyka AI’s model projects a near-term quarterly price of C$0.72, implying -25.00% from today. The company sits in Healthcare where typical P/E is higher than Healwell AI’s metrics, so valuation re-rating depends on operational improvements and earnings guidance. Given a current ratio below 1.00 and negative cash flow per share, the stock carries execution and liquidity risk. Our Meyka grade is B (62.15) with a HOLD suggestion, reflecting mixed growth signals and sector pressures. Traders may prefer to watch the earnings print and management guidance before adjusting position sizes. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.